A Randomized, Double-Blind, Double-Dummy, Placebo- and Active-Controlled Crossover Study to Evaluate the Abuse Potential of Single Doses of Lorcaserin in Healthy Recreational Polydrug Users
Phase of Trial: Phase I
Latest Information Update: 20 Mar 2010
At a glance
- Drugs Ketamine; Lorcaserin; Zolpidem
- Indications Drug abuse; Obesity
- Focus Pharmacodynamics
- Sponsors Arena Pharmaceuticals
- 20 Mar 2010 Results have been presented at the 111th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics.
- 10 Dec 2009 Positive data has been reported at the 48th Annual Meeting of the American College of Neuropsychopharmacology, according to an Arena Pharmaceuticals media release.